What does this service help with?
Combining components, intended uses, agent types, routes of delivery, label declarations and enterprise targets, collating possible drug routes and issues to continue verification; The preliminary assessment does not constitute a formal decision by the FDA, and we will first identify the specific matters to be addressed and the scope of collaboration, taking into account product categories and the applicability of current information.